youth usag reduct take time
boost po
net dbt
outgo fda commission speak washington
tuesday afternoon outgo fda commission gottlieb spoke washington
accord bloomberg dr gottlieb describ recent meet altria/juul
repres difficult appear concern lack progress
juul/mo make regard epidem youth access press report
note fda go care calcul action
entir categori pod-bas product suggest fda may need pull pod-
base nicotine-bas product market share fell
balanc youth usag adult access
rememb gottlieb outgo fda commission agenda
like move forward fda agenda could modifi chang direct
next perman fda commission last decad mo publicli support
fda oversight tobacco opinion mo gold standard term us
complianc mo/juul publicli advoc legal purchas age
pull pod flavor ex tobacco mint menthol non-enhanc age
verif outlet chang youth behavior happen overnight
fda manufactur retail educ work toward goal
expect eventu see needl move right direct youth access/usag
howev also see need keep adult smoker access pod order move
combust cigarett smoker risk continuum
reiter buy boost po
see mo best posit us tobacco co adapt chang
landscap strong core busi juul/cannabi stake believ mo
continu manag busi long run price action profit focu
unwav sharehold commit last mo trade line
incl pressur grant fda oversight tobacco
menthol ban threat larg fedl tobacco tax hike surg juul result
lift po base price-to-earnings ep estimate
discount current forward pe see
warrant given fda concern previou p/ex valuat ep
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
parent compani philip morri
cigar michel wine estat philip
morri capit corp pmusa enjoy share
us cigarett market led top cigarett
brand marlboro mo also own
anheuser-busch inbev world largest brewer
march spun int cigarett
busi sharehold decemb
acquir juul lab
see long term benefit recent
invest juul lab crono steadi
earn growth abil balanc price
growth declin cigarett vol
commit dividend pay-out ratio
attract valuat lack fx exposur
reason maintain buy recommend
addit us smoker appear better shape
po base price-to-earnings ep estimate
current forward price-to-earnings impli near discount current
forward price-to-earnings see warrant given fda concern
downsid risk po unfavor fda regul current
envis unfavor taxat deeper secular declin estim upsid risk
faster shift non-combust tobacco product current envis better
expect cost cut net price
lisa lewandowski herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
